檢索結果 - Tan, Daniel SW
- Showing 1 - 20 results of 23
- Go to Next Page
-
1
-
2
-
3
Overcoming the impact of the COVID‐19 pandemic on oncology early phase trials and drug development in Asia—Experiences and perspectives of the Asian Oncology Early Phase 1 Consorti... 由 Shimizu, Toshio, Kim, Dong‐Wan, Loong, Herbert H., Lin, Chia‐Chi, Ng, Matthew CH, Yamamoto, Noboru, Ma, Brigette, Tan, Daniel SW
出版 2021Text -
4
-
5
Targeting Cancer Stem Cell Plasticity Through Modulation of Epidermal Growth Factor and Insulin-Like Growth Factor Receptor Signaling in Head and Neck Squamous Cell Cancer 由 Leong, Hui Sun, Chong, Fui Teen, Sew, Pui Hoon, Lau, Dawn P., Wong, Bernice H., Teh, Bin-Tean, Tan, Daniel S.W., Iyer, N. Gopalakrishna
出版 2014Text -
6
-
7
Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib 由 Gainor, Justin F., Tan, Daniel S.W., De Pas, Tomasso, Solomon, Benjamin J., Ahmad, Aziah, Lazzari, Chiara, de Marinis, Filippo, Spitaleri, Gianluca, Schultz, Katherine, Friboulet, Luc, Yeap, Beow Y., Engleman, Jeffrey A., Shaw, Alice T.
出版 2015Text -
8
Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3‐Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF Alte... 由 Bardia, Aditya, Gounder, Mrinal, Rodon, Jordi, Janku, Filip, Lolkema, Martijn P., Stephenson, Joe J., Bedard, Philippe L., Schuler, Martin, Sessa, Cristiana, LoRusso, Patricia, Thomas, Michael, Maacke, Heiko, Evans, Helen, Sun, Yongjian, Tan, Daniel S.W.
出版 2019Text -
9
Ceritinib Efficacy and Safety in Treatment-Naive Asian Patients With Advanced ALK-Rearranged NSCLC: An ASCEND-4 Subgroup Analysis 由 Tan, Daniel S.W., Geater, Sarayut, Yu, Chong-Jen, Tsai, Chun-Ming, Hsia, Te-Chun, Chen, Jun, Lin, Meng-Chih, Lu, You, Sriuranpong, Virote, Yang, Cheng-Ta, Sen, Paramita, Branle, Fabrice, Shi, Michael, Wu, Yi-Long
出版 2020Text -
10
Microfluidic enrichment for the single cell analysis of circulating tumor cells 由 Yeo, Trifanny, Tan, Swee Jin, Lim, Chew Leng, Lau, Dawn Ping Xi, Chua, Yong Wei, Krisna, Sai Sakktee, Iyer, Gopal, Tan, Gek San, Lim, Tony Kiat Hon, Tan, Daniel S.W., Lim, Wan-Teck, Lim, Chwee Teck
出版 2016Text -
11
Clinical Characteristics and Outcomes in Advanced KRAS-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005) 由 Lee, Jiyun, Tan, Aaron C., Zhou, Siqin, Yoon, Shinkyo, Liu, Siyang, Masuda, Ken, Hayashi, Hidetoshi, Batra, Ullas, Kim, Dong-Wan, Goto, Yasushi, Tan, Sze Huey, Wu, Yi-Long, Lee, Dae Ho, Tan, Daniel S.W., Ahn, Myung-Ju
出版 2021Text -
12
Bosutinib inhibits migration and invasion via ack1 in kras mutant non-small cell lung cancer 由 Tan, Daniel SW, Haaland, Benjamin, Gan, Jia Min, Tham, Su Chin, Sinha, Indrajit, Tan, Eng Huat, Lim, Kiat Hon, Takano, Angela, Krisna, Sai Sakktee, Thu, Minn Minn Myint, Liew, Hoe Peng, Ullrich, Axel, Lim, Wan-Teck, Chua, Boon Tin
出版 2014Text -
13
Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion–Positive NSCLC 由 Drilon, Alexander, Chiu, Chao-Hua, Fan, Yun, Cho, Byoung Chul, Lu, Shun, Ahn, Myung-Ju, Krebs, Matthew G., Liu, Stephen V., John, Thomas, Otterson, Gregory A., Tan, Daniel S.W., Patil, Tejas, Dziadziuszko, Rafal, Massarelli, Erminia, Seto, Takashi, Doebele, Robert C., Pitcher, Bethany, Kurtsikidze, Nino, Heinzmann, Sebastian, Siena, Salvatore
出版 2022Text -
14
BM-32 CERITINIB (LDK378) FOR TREATMENT OF PATIENTS WITH ALK-REARRANGED (ALK+) NON-SMALL CELL LUNG CANCER (NSCLC) AND BRAIN METASTASES (BM) IN THE ASCEND-1 TRIAL 由 Shaw, Alice, Mehra, Ranee, Tan, Daniel S.W., Felip, Enriqueta, Chow, Laura Q.M., Ross Camidge, D., Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Geraldes, Margarida, Sen, Paramita, Boral, Anthony J., Yovine, Alejandro, Kim, Dong-Wan
出版 2014Text -
15
Human Tumor-Infiltrating MAIT Cells Display Hallmarks of Bacterial Antigen Recognition in Colorectal Cancer 由 Li, Shamin, Simoni, Yannick, Becht, Etienne, Loh, Chiew Yee, Li, Naisi, Lachance, Daniel, Koo, Si-Lin, Lim, Teck Por, Tan, Emile Kwong Wei, Mathew, Ronnie, Nguyen, Andrew, Golovato, Justin, Berkson, Julia D., Prlic, Martin, Lee, Bernett, Minot, Samuel S., Nagarajan, Niranjan, Dey, Neelendu, Tan, Daniel S.W., Tan, Iain B., Newell, Evan W.
出版 2020Text -
16
Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer 由 Shaw, Alice T., Kim, Dong-Wan, Mehra, Ranee, Tan, Daniel S.W., Felip, Enriqueta, Chow, Laura Q.M., Camidge, D. Ross, Vansteenkiste, Johan, Sharma, Sunil, De Pas, Tommaso, Riely, Gregory J., Solomon, Benjamin J., Wolf, Juergen, Thomas, Michael, Schuler, Martin, Liu, Geoffrey, Santoro, Armando, Lau, Yvonne Y., Goldwasser, Meredith, Boral, Anthony L., Engelman, Jeffrey A.
出版 2014Text -
17
Intracranial Efficacy of Selpercatinib in RET Fusion-Positive Non–Small Cell Lung Cancers on the LIBRETTO-001 Trial 由 Subbiah, Vivek, Gainor, Justin F., Oxnard, Geoffrey R., Tan, Daniel S.W., Owen, Dwight H., Cho, Byoung Chul, Loong, Herbert H., McCoach, Caroline E., Weiss, Jared, Kim, Yu Jung, Bazhenova, Lyudmila, Park, Keunchil, Daga, Haruko, Besse, Benjamin, Gautschi, Oliver, Rolfo, Christian, Zhu, Edward Y., Kherani, Jennifer F., Huang, Xin, Kang, Suhyun, Drilon, Alexander
出版 2021Text -
18
Mutational landscapes of tongue carcinoma reveal recurrent mutations in genes of therapeutic and prognostic relevance 由 Vettore, Andre Luiz, Ramnarayanan, Kalpana, Poore, Gregory, Lim, Kevin, Ong, Choon Kiat, Huang, Kie Kyon, Leong, Hui Sun, Chong, Fui Teen, Lim, Tony Kiat-Hon, Lim, Weng Khong, Cutcutache, Ioana, Mcpherson, John R., Suzuki, Yuka, Zhang, Shenli, Skanthakumar, Thakshayeni, Wang, Weining, Tan, Daniel SW, Cho, Byoung Chul, Teh, Bin Tean, Rozen, Steve, Tan, Patrick, Iyer, N. Gopalakrishna
出版 2015Text -
19
A three gene immunohistochemical panel serves as an adjunct to clinical staging of patients with head and neck cancer 由 Ong, Chin-Ann J., Shannon, Nicholas B., Mueller, Stefan, Lek, Sze Min, Qiu, Xuan, Chong, Fui Teen, Li, Ke, Koh, Kelvin K.N., Tay, Gerald C.A., Skanthakumar, Thakshayeni, Hwang, Jacqueline S.G., Hon Lim, Tony Kiat, Ang, Mei Kim, Tan, Daniel S.W., Tan, Ngian-Chye, Tan, Hiang Khoon, Soo, Khee Chee, Iyer, N. Gopalakrishna
出版 2017Text -
20
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer 由 Nanjo, Shigeki, Wu, Wei, Karachaliou, Niki, Blakely, Collin M., Suzuki, Junji, Chou, Yu-Ting, Ali, Siraj M., Kerr, D. Lucas, Olivas, Victor R., Shue, Jonathan, Rotow, Julia, Mayekar, Manasi K., Haderk, Franziska, Chatterjee, Nilanjana, Urisman, Anatoly, Yeo, Jia Chi, Skanderup, Anders J., Tan, Aaron C., Tam, Wai Leong, Arrieta, Oscar, Hosomichi, Kazuyoshi, Nishiyama, Akihiro, Yano, Seiji, Kirichok, Yuriy, Tan, Daniel S.W., Rosell, Rafael, Okimoto, Ross A, Bivona, Trever G.
出版 2022Text